The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2024 | Factors to consider when using haplo-SCT: donor selection criteria and source of stem cells
Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses factors that should be considered for patients undergoing haploidentical stem cell transplantation (haplo-SCT). He highlights how donor selection criteria vary depending on whether anti-thymocyte globulin (ATG) or post-transplantation cyclophosphamide (PTCy) is utilized for immunosuppression. Additionally, Prof. Nagler compares bone marrow (BM) and peripheral blood (PB) as stem cell sources. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
